Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands

Linda Härmark; Gerda Weits; Rietje Meijer; Federica Santoro; G Niklas Norén; Florence van Hunsel

doi:10.1007/s40264-020-00970-z

Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands

Drug Saf. 2020 Aug;43(8):823. doi: 10.1007/s40264-020-00970-z.

Authors

Linda Härmark¹, Gerda Weits², Rietje Meijer³, Federica Santoro⁴, G Niklas Norén⁴, Florence van Hunsel²

Affiliations

¹ Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands. l.harmark@lareb.nl.
² Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands.
³ Netherlands Thyroid Organization, Stationsstraat 79 G, 3811 MH, Amersfoort, The Netherlands.
⁴ Uppsala Monitoring Centre, Bredgränd 7, Uppsala, Sweden.

Abstract

The article "Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands", written by Linda Härmark, Gerda Weits, Rietje Meijer, Federica Santoro, G. Niklas Norén, Florence van Hunsel, was originally published electronically on 16 May 2020 without open access.

Publication types

Published Erratum